Literature DB >> 2302178

Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids.

M J Watts1, J R Dankert, E P Morgan.   

Abstract

We have previously reported the isolation of a membrane-attack-complex-inhibiting protein (MIP) from human erythrocyte membranes [Watts, Patel & Morgan (1987) Complement 4, 236] and the production of polyclonal antibodies to this protein. Here we report the identification in plasma, urine, saliva and cerebrospinal fluid of a protein immunochemically identical with the membrane-derived MIP. The protein has been isolated from plasma by immunoaffinity chromatography on an anti-(erythrocyte MIP)-Sepharose column and shown by SDS/polyacrylamide-gel electrophoresis to be of similar molecular mass to the erythrocyte protein (55 kDa non-reduced and 65 kDa under reducing conditions). Monoclonal antibodies have been raised against plasma MIP and used to establish a two-site enzyme-linked immunoadsorbent assay, enabling quantification of MIP in plasma, urine and cerebrospinal fluid. Plasma MIP, though not able to incorporate spontaneously into membranes, was deposited on heterologous and homologous erythrocyte membranes during complement activation in a C8-dependent manner. Depletion of MIP from plasma resulted in enhancement of the lytic capacity of the plasma on heterologous erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302178      PMCID: PMC1136908          DOI: 10.1042/bj2650471

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.

Authors:  K I Yamamoto
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

2.  Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.

Authors:  L S Zalman; L M Wood; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.

Authors:  G R Nemerow; K I Yamamoto; T F Lint
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

4.  Immunoaffinity purification of human complement component C9 using monoclonal antibodies.

Authors:  B P Morgan; R A Daw; K Siddle; J P Luzio; A K Campbell
Journal:  J Immunol Methods       Date:  1983-11-25       Impact factor: 2.303

5.  Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Authors:  G M Hänsch; C H Hammer; P Vanguri; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.

Authors:  E R Podack; K T Preissner; H J Müller-Eberhard
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1984

8.  Decreased C5b67-inhibitor activity in two families with hereditary functional deficiency of the eighth component of complement.

Authors:  H J Zeitz; R A Zeff; H Gewurz; T F Lint
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

9.  Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.

Authors:  S Schönermark; E W Rauterberg; M L Shin; S Löke; D Roelcke; G M Hänsch
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

10.  Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.

Authors:  L S Zalman; L M Wood; M M Frank; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  23 in total

1.  Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.

Authors:  J H Sohn; H J Kaplan; H J Suk; P S Bora; N S Bora
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

2.  Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

Review 3.  Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.

Authors:  C J Parker
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  Molecular basis for a link between complement and the vascular complications of diabetes.

Authors:  J Acosta; J Hettinga; R Flückiger; N Krumrei; A Goldfine; L Angarita; J Halperin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 5.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

7.  Regulation of complement membrane attack complex formation in myocardial infarction.

Authors:  A Väkevä; P Laurila; S Meri
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

8.  Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions.

Authors:  D P Witte; B J Aronow; M L Stauderman; W D Stuart; M A Clay; R A Gruppo; S H Jenkins; J A Harmony
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

9.  Membrane attack complex (MAC)-mediated damage to spermatozoa: protection of the cells by the presence on their membranes of MAC inhibitory proteins.

Authors:  I A Rooney; A Davies; B P Morgan
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

10.  Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells.

Authors:  N Tandon; B P Morgan; A P Weetman
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.